MedTrace Logo

Surveillance Study of Women Taking Intrinsa®

NCT00551785 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 328

Last updated 2015-03-25

No results posted yet for this study

Summary

The primary objective of the study is to assess the risks of testosterone transdermal patch use in a representative study population. The primary clinical outcome of interest is breast cancer.

Conditions

  • Ovariectomy
  • Hysterectomy
  • Hypoactive Sexual Desire Disorder

Sponsors & Collaborators

  • Procter and Gamble

    collaborator INDUSTRY

  • Center for Epidemiology and Health Research, Germany

    lead OTHER

Principal Investigators

  • Klaas Heinemann, MD, PhD · Center for Epidemiology and Health Research, Germany

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00551785 on ClinicalTrials.gov